企业QQ
官方微信
蚂蚁淘(ebiomall)是苏州蚂蚁淘生物科技有限公司旗下的生物医学科研用品跨境直采（平行进口）平台，自营B2B电商。客户在蚂蚁淘搜索全球产品信息，找到合适的产品后再蚂蚁淘下单，然后蚂蚁淘的海外办事处进行跨境采购、运输到中国口岸，最后由蚂蚁淘国内团队清关并发货给客户
我们部分客户
1 : 经销商代表---国药化试，飞世尔，SIGMA等1000家左右的经销商
2 : 学校代表---北京大学，清华大学，上海交通大学，复旦大学，武汉大学，厦门大学.....等200所左右大学及100多家附属医院
3 : 制药公司代表 : 罗氏，阿斯利康，诺和诺德，和记黄埔，东阳光科......
4 : CRO公司代表 : 睿智化学，药明康德，桑迪亚，美迪西......
我们专有的细胞粘附矩阵（CAM）技术能够分离和分析转移性肿瘤细胞。
通过早期发现侵袭性疾病，选择合适的药物并监测治疗，应用的DNA分析可能会使患者受益。
开发新的癌症药物的公司可以使用新的转移和检测服务模型，从而改善临床试验中的患者选择和监测，并发现新药物。
Vitatex is focused on advance personalized medicine with tests of invasive circulating tumor cells (iCTCs) that provide better information about the metastatic potential of a patient’s cancer to improve treatment and reduce health care costs. The company’s unique advantage stems from its patented approach that captures iCTCs directly linked to the metastatic process.
Leveraging its functional Cell Adhesion Matrix (CAM) technology, Vitatex is developing proprietary diagnostic tests that can be run on blood samples, collected by standard current methods, to improve cancer treatment decisions and select effective therapies for recurrence and metastatic diseases.
Improved Cancer Drug Selection: iCTCs captured by the Vitatex method are alive and can readily be cultured in the presence of panels of cancer drugs to optimize selection of treatment tailored to each patient. The ability to determine which cancer drug or drug cocktail is most likely to benefit a patient meets a major need which currently available methods have had only limited ability to address.
Better Prognostic Information: CAM-captured iCTCs can be sorted and counted by automated flow cytometry to provide an early indication of metastasis in pre-operative patients, as well as early detection of recurrence in patients under therapeutic treatment. This greatly improved prognostic information can help the physician decide on aggressive chemo- therapy or other strategies more rapidly and confidently.
Convenient and Effective Treatment Monitoring: Serial measurement of iCTCs in routinely collected patient blood samples during the course of treatment and beyond can monitor for effective response, relapse to allow a timely change of a failing therapy, or to reinitiate therapy following recurrence.
The company’s technology also creates significant opportunities for research products and services that advance development of new cancer drugs and novel cancer markers, as well as support metastasis research. Companies developing new cancer drugs can access new models of metastasis and assay services that improve patient selection and monitoring in clinical trials. Vitatex has also developed proprietary metastatic cell lines and protein markers of invasiveness, including Seprase and DPP4, which strengthen the company’s testing methods and have potential cancer drug development applications.
Vitatex has translated its patented CAM iCTC technology platform into a pipeline of promising innovative diagnostic tests that have entered clinical studies, and into enabling new research products and services. The company is pursuing these opportunities both through its own initiatives and through partnerships being developed with major diagnostic and research tool and service companies
在治疗过程中及以后，定期采集患者血液样本中iCTC的系列测量结果可以监测有效的反应，复发以及时更换失败的治疗方法或在复发后重新开始治疗。
尽管将近80％的卵巢癌患者对标准化疗有反应，但其中一半在一年内复发。肺癌和胰腺癌的复发率相似。
但是，当前的CT成像和血清CA125方法检测到复发太晚，无法有效治疗。也缺乏从30多种可用疗法中进行选择的方法。
Applied DNA开发了独特的浸润性循环肿瘤细胞（iCTC）技术，可从血液中富集iCTC，以用于复发的早期诊断和治疗选择。
在常规CT成像和血清CA125发现复发证据之前的六个月，iCTC™分析能够检测卵巢癌的复发。
通过CT成像，血清CA125和iCTC对卵巢癌复发进行筛查。
热心细致的服务态度打造温暖亲切的购物氛围，有任何问题欢迎随时联系我们！
苏州蚂蚁淘生物科技有限公司
SuZhouebiomall BIOLOGicalTechnologyCo.,Ltd.
总部地址:苏州园区星湖街218号苏州生物医药产业园一期（生物纳米园）A4-216
服务热线:4000-520-616（限工作日9:00-18:00）
固话：
手机：18915418616
QQ：3507623898、3464842061、1570468124
传真:
Email:info@ebiomall.com